Qingjian Li
107 Yanjiang West Road
Guangzhou, 510120, China
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Impact of intraoperative radiotherapy vs. whole-breast external beam radiotherapy for early breast cancer: a propensity score matching study based on SEER database.
Journal: Gland surgery
Published: February 09, 2025
A TNBC-targeting nano-radiosensitizer reverses radioresistance by synergizing GSH scavenging with dual inhibition of Trop2 and lncRNA MNX1-AS1.
Journal: Biomaterials
Published: December 11, 2024
Circular RNA circ_ARHGEF28 inhibits MST1/2 dimerization to suppress Hippo pathway to induce cisplatin resistance in ovarian cancer.
Journal: Cancer cell international
Published: February 12, 2024
The global patent landscape of HER2-targeted biologics.
Journal: Nature biotechnology
Published: June 14, 2023
Novel blood-based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non-small-cell lung cancer: Results from two multicenter, randomized clinical trials.
Journal: Clinical and translational medicine
Published: June 09, 2020
Nanoparticles (NPs)-Meditated LncRNA AFAP1-AS1 Silencing to Block Wnt/β-Catenin Signaling Pathway for Synergistic Reversal of Radioresistance and Effective Cancer Radiotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 12, 2020
Long Non-Coding RNA MNX1-AS1 Promotes Progression of Triple Negative Breast Cancer by Enhancing Phosphorylation of Stat3.
Journal: Frontiers in oncology
Published: February 24, 2020
Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade.
Journal: Cell reports
Published: November 26, 2019
Last Updated: 09/26/2026